1. Introduction {#sec1}
===============

The National Center for Complementary and Alternative Medicine (NCCAM) defines complementary and alternative medicine (CAM) as "diverse medical and healthcare systems, practices and products that are not generally considered a part of conventional medicine" \[[@B1]\]. Despite advances in the medical treatment of cancer that have resulted in improved cure rates, the incidence of cancer is increasing, and it remains a leading cause of death \[[@B2]\]. At the same time, there is an increasing tendency for patients with cancer to use CAM by \[[@B3]\]. In patients with breast cancer, the rate of CAM use increased from 67% to 82% between 1998 and 2005 \[[@B4]\]. Furthermore, CAM use was reported in up to 90% of patients with cancer in the United States \[[@B5], [@B6]\] and 44.6% of those in Japan \[[@B7]\].

From a clinical perspective, it is important to identify factors that encourage large numbers of patients with cancer to use CAM, solely or concomitantly with conventional medical treatments, because cancer patients frequently face situations that are subjectively less controllable and more frightening than other chronic or life-threatening diseases \[[@B8]\]. Previous studies have suggested that the rate of CAM use depends on sociodemographic characteristics of patients, cancer-related clinical characteristics, regional and cultural factors, and patients\' patterns of coping with the disease \[[@B9]\]. Younger age \[[@B7], [@B10]\], female gender \[[@B10], [@B11]\], a higher level of education \[[@B7], [@B10], [@B12]\], and higher income and social class \[[@B10], [@B11]\] seem to be associated with more frequent use of CAM. Additionally, it has been reported that a higher rate of CAM use is associated with a longer duration since diagnosis \[[@B13]\], progression of the cancer \[[@B10], [@B12], [@B14]\], and a lower degree of trust in physicians \[[@B10], [@B15]\].

Meanwhile, few studies have been conducted to examine the relationship between the unmet informational needs and the use of CAM in patients with cancer, although the topic of unmet needs has been a recurrent on in CAM-related studies \[[@B10]\]. In patients with cancer, informational support provides a sense of control over the illness \[[@B16]\] and enhances patients\' quality of life when information meets their needs \[[@B17]\]. Accordingly, unmet needs for information may cause distress in patients \[[@B18]\], thus possibly affecting their pattern of use of medical services. It is thus important that the degree of patient need for information is examined as a possible predictor of CAM use.

In Korea to date, almost no nationwide studies have been reported examining the use of CAM and relevant factors. Most previous studies have been conducted at a few hospitals in a specific region. The rate of CAM use varies depending on the study; it was reported to be 63.7% by Kim \[[@B19]\], 55.5% by Lee et al. \[[@B20]\], and 56.9% by Park and Lee \[[@B21]\]. It is worthwhile to examine the current status of CAM use in patients with cancer and to develop the best policy for them. To do this, it is important to collect baseline data that can be generalized for various types of cancer in varying stages. This should also be accompanied by access to comprehensive cancer care to achieve a better understanding of the factors affecting CAM use and relevant reasons.

Given this background, we conducted this study with the following objectives: (1) to evaluate the status of CAM use based on nationwide data in patients with various types of cancer; (2) to examine factors affecting CAM use, including socioeconomic, clinical, and individual factors, in patients with cancer; and (3) to identify any association between informational needs and CAM use in patients with cancer.

2. Materials and Methods {#sec2}
========================

2.1. Study Patients and Procedure {#sec2.1}
---------------------------------

For the current study, we collected data from patients with cancer who were treated at the National Cancer Center or nine regional cancer centers in Korea during the period from July to August 2008. Quota sampling was used: 80% of the patients had been diagnosed with one of six major types of cancer (stomach, lung, liver, colon and rectum, breast, and cervix), and the remaining 20% had other types of cancer. The patients were interviewed by trained interviewers at their treatment centers. Inclusion criteria were (1) age \>18 years old, (2) an established diagnosis of cancer, (3) a period \>4 months since the diagnosis, (4) current treatments or follow-ups, and (5) written informed consent for study participation. Detailed procedures have been described elsewhere \[[@B22]\]. In total, 2,661 patients with cancer completed an interview. Then, through a retrospective analysis of the patients\' medical records, we obtained clinical data such as types, histology, and SEER stage of the cancers. The current study was approved by the institutional review board (IRB) of the National Cancer Center in Korea.

2.2. Measurement and Analysis of the Patient Data {#sec2.2}
-------------------------------------------------

A questionnaire survey was designed to collect data about CAM use and potential predictors (sociodemographic and clinical factors, quality of life, the degree of trust in physicians and hospitals, degree of satisfaction with conventional medicine, and degree of need for information).

We defined CAM based on the widely established NCCAM taxonomy \[[@B1]\] and included alternative medical systems, mind and body interventions, natural products, manipulative and body-based methods, and energy therapies. The specific CAM modalities asked about in this study were traditional Chinese medicine, ayurveda, herbalism, acupuncture, meditation, yoga, biofeedback, hypnosis, relaxation, imagery, prayer, chiropractic, massage, special diets, dietary supplements, qi gong, and healing touch. According to NCCAM, we did not include pure psychotherapeutics or support groups, and we excluded general exercises to avoid overestimation.

In the questionnaire survey, patients were asked about their experience using CAM with the question, "Have you ever used complementary and alternative medicines (CAM) since you were diagnosed with cancer?" Patient responses were collected as a dichotomized variable. Sociodemographic factors included age, gender, education, income, marital status, and health insurance status. Clinical factors included the type of cancer, SEER stage, treatment, time since the diagnosis, and current disease status. Additionally, quality of life was measured using the EQ5D, which measures five dimensions of patient quality of life (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) using a 3-point scoring system (1 = no problem, 2 = some problems, and 3 = severe problems). The EQ5D has been validated for Korean subjects \[[@B23]\]. We classified responses to the EQ5D into two categories: patients who had at least one problem and those who had no problem.

The degree of trust in physicians and hospital was measured using a 5-point Likert scale (1 = strongly disagree and 5 = strongly agree), and responses were classified into three categories: very satisfied, somewhat satisfied, and not satisfied.

The overall degree of satisfaction with conventional cancer care was measured with a 5-point Likert scale (1 = very dissatisfied and 5 = very satisfied), and responses were then dichotomized (satisfied or very satisfied versus others) for further analyses.

The degree of patient need for information was measured using a subscale of the Comprehensive Needs Assessment Tool (CNAT) in cancer, which has been validated for Korean subjects \[[@B24]\]. Patients were instructed to evaluate items on a 4-point scale (never needed, slightly needed, moderately needed, and highly needed) based on the past month\'s experience. Responses were then classified for further analysis into binary variables: "never needed" versus "needed" (slightly needed, moderately needed, or highly needed).

2.3. Statistical Analysis {#sec2.3}
-------------------------

We used the chi-squared test to analyze differences in the rates of CAM use between the categories of selected demographic and clinical variables (age, gender, education, marital status, monthly income, national health insurance, cancer type, metastasis, SEER stage, and time since diagnosis). Additionally, we performed a univariate analysis of factors predicting CAM use. Then, we entered variables found to be significantly associated with CAM use in the univariate analysis into a multiple logistic regression model. The criterion for variable entry was *P* = 0.05. Age, gender, education, monthly income, cancer type, metastasis, and time since diagnosis were included in a basic predictive model. EQ5D, trust in physicians and hospitals, overall degree of satisfaction with the conventional cancer care, and degree of patient need for information were also analyzed individually for their associations with the use of CAM following adjustment of variables in the basic model. Data from patients with missing values were excluded from the multiple logistic regression model. All statistical analyses were performed using the SAS 9.2 software (SAS Institute, Cary, NC, USA). Statistical significance was set at *P* \< 0.05.

3. Results {#sec3}
==========

[Table 1](#tab1){ref-type="table"} summarizes baseline characteristics of all study patients, including those who used CAM. Of the 2,661 total respondents, 25.5% responded that they had used CAM. The rate of CAM use was relatively higher in women, the age group between 40 and 59 years, and the group with monthly household income over USD 3000. With regard to type of cancer, CAM use was relatively higher in patients with breast cancer. It was also relatively higher in patients who had metastasis, those with a longer duration since diagnosis, those who had a lower degree of trust in physicians or hospitals, and those who had a lower overall degree of satisfaction with the cancer treatment offered by hospitals. Furthermore, from the perspective of quality of life, the rate of CAM use was relatively higher in patients who responded that they had a problem in more than one area covered by the five EQ5D questions.

A univariate analysis was performed for the variables presented in [Table 1](#tab1){ref-type="table"}. This was followed by a multivariate analysis of variables showing a significant association with CAM use. The basic model included variables of gender, age, education, monthly income, cancer type, metastasis, and timing of diagnosis. Variables showing a significant association with CAM use in the univariate analysis, including gender, age, and education, no longer showed significant associations or showed a lower degree of association following adjustment for other variables. However, monthly income, cancer type, metastasis, and the duration since diagnosis maintained significant associations with CAM use even following the adjustment for other variables. Next, we performed a multivariate logistic regression analysis including trust in physicians and hospitals, overall degree of satisfaction with conventional medical service, and the EQ5D scores individually in a basic model. Even after controlling for socioeconomic and clinical factors, lower degree of trust in physicians or hospitals (aOR 2.38, 95% CI 1.13--5.00; aOR 2.04, 95% CI 1.15--3.63, resp.), and lower overall degree of satisfaction with the hospital (aOR 1.61, 95% CI 1.11--2.34) were significantly associated with the use of CAM. With regard to EQ5D, the patients who responded that they had a problem in one or more of the areas addressed in the EQ5D were 1.23 times (95% CI 1.01--1.50) more likely to use CAM compared with those who responded that they had no problems ([Table 2](#tab2){ref-type="table"}).

The analysis of the association between the use of CAM and the degree of patient need for information indicated that CAM use was predicted by higher degree of informational need. Patients who responded that they were in need of information about the status and further course of the disease, the test and treatment methods, correct diet, and availability of financial support for patients with cancer were more likely to use CAM. Of the nine questions related to this issue, only the question about hospice showed no significant association with the use of CAM ([Table 3](#tab3){ref-type="table"}).

4. Discussion {#sec4}
=============

We conducted the current multicenter study to extensively analyze factors affecting the rate of CAM use in patients with various cancers in varying stages. Our results showed that sociodemographic factors affected the use of CAM, consistent with previous studies \[[@B7], [@B10]--[@B12]\]. A multivariate analysis showed that such sociodemographic factors as younger age (but not the youngest) and high monthly income had a significant association with the rate of CAM use. A higher level of education was also a marginal predictor of CAM use. Moreover, clinical factors, including metastasis, primary cancer site, and time since diagnosis, were also significantly associated with the use of CAM even after adjustment for sociodemographic factors. The result that metastatic cancer patients were more likely to use CAM suggests that patients at an advanced stage tend to use every method available to supplement conventional medicine. The association between progression of cancer and CAM use has been reported previously \[[@B10], [@B12], [@B14]\]. According to Paltiel et al., a poor progress may lead to increased level of concern or distress and a desire to explore all possible options. Our results also showed that the rate of CAM use was relatively higher in patients with breast cancer, also in agreement with previous reports \[[@B25]--[@B27]\]. It has been reported worldwide that the rate of CAM use is highest in patients with breast cancer \[[@B26]\]. This finding may be confounded by the fact that more women use CAM than men \[[@B28]\] and should be interpreted cautiously. Gender was included as a variable in a multivariate analysis, which might dilute the association between gender and use of CAM in patients with breast cancer. On the other hand, it is also probable that the gender-related difference in the rate of CAM use might be diluted following the adjustment for breast cancer. Our results might be interpreted in the latter manner.

After controlling for basic factors in the multivariate analysis, the degree of trust in physicians and hospitals was strongly associated with the use of CAM. A lower degree of trust in physicians was associated with more frequent use of CAM, and the same was also true of the association between the degree of trust in hospitals and CAM use. This is supported by several studies. According to Cassileth et al., doctor-patient relationships were worse in patients who underwent both conventional therapy and CAM compared with patients who underwent conventional therapy alone \[[@B15]\]. Additionally, Paltiel et al. reported that the rate of CAM use was relatively lower in patients who had a higher degree of trust in physicians \[[@B10]\].

Our results showed that overall degree of satisfaction with conventional medicine was also a predictor of CAM use. However, this remains controversial. It has been reported that patients tend to use CAM unless they are satisfied with conventional medicine \[[@B10], [@B29]\]. Thus, many oncologists worry that patients would discontinue current treatments with the purposes of using CAM alternatively to conventional medicine. On the other hand, there are also contradictory results that dissatisfaction with conventional treatment was not a predictor of CAM use \[[@B30]\], and patients who used CAM expressed as high a degree of trust in conventional medicine and showed as high a degree of compliance as patients who were not interested in CAM \[[@B9]\]. Further studies are needed to clarify the relationship between satisfaction with conventional medicine and CAM use conclusively.

Interestingly, patients who had a greater need for information were more likely to use CAM. According to the questionnaire survey, based on the responses to the nine questions about the degree of patient need for information, other than the question about hospice, a higher degree of informational need was associated with a higher rate of CAM use. These results can be interpreted from two perspectives. (1) A coping style might be involved. That is, patients tend to consider the use of CAM as a way of independently contributing to their treatment if they have an active coping style against the disease and consider their prognosis somewhat hopeful (and their need for information about hospice is accordingly lower). Söllner et al. reported that a coping style characterized by information seeking and active problem solving was a powerful independent predictor of CAM use \[[@B9]\]. (2) The correlation between CAM use and the degree of informational needs may be considered from the perspective of unmet needs. The concept of unmet needs in cancer patients comprises several aspects including information, psychological problems, physical symptoms, and emotional needs \[[@B31]\]. If patients with cancer have unmet needs that include informational aspects, this would tend to decrease the degree of satisfaction with conventional treatment and/or the trust in physicians or hospitals, which might in turn increase the rate of CAM use. It has been reported that patient satisfaction with medical treatments is increased when patients are appropriately provided with information \[[@B32]\]. Following the analysis of data obtained in the current study, a higher degree of informational need was correlated with lower overall satisfaction with conventional medical services and trust in hospitals and a lower degree of trust in physicians or hospitals (data not shown). Due to limitations of this cross-sectional study, however, it was difficult to identify any causal relationship between the variables.

In our clinical series, the overall rate of CAM use following the diagnosis of cancer was 25.5%. This is notably lower than previously reported: 44.6% in Japan \[[@B7]\], 61.5% in Australia \[[@B12]\], 51.2% in Israel \[[@B10]\], and 78--90% in the United States \[[@B3], [@B5], [@B6], [@B33]\]. Moreover, it is quite different from the 55--65% in previous Korean reports \[[@B19]--[@B21]\]. One possible explanation for this low rate is a slight difference in the definition of CAM between this and the previous studies. Although many studies \[[@B3], [@B5], [@B6], [@B12], [@B19]--[@B21]\] defined CAM based on the NCCAM, some \[[@B7], [@B33]\] used operational definitions of their own, and one study was based on a Cochrane collaboration \[[@B10]\]. Moreover, even if based on NCCAM, the specific modalities of each CAM category listed in the questionnaires varied among the studies. For example, our study excluded general physical exercises, while yoga and qi gong were included in the exercises as CAM. However, many studies did not distinguish between movement therapies and general physical exercises \[[@B3], [@B6], [@B12], [@B19]--[@B21]\]. Similarly, the exclusion of support groups and psychotherapy from our definition of CAM may have influenced the result. Another possible explanation for the rate differences is the questionnaire survey method. In studies that reported a high rate of CAM use, the questionnaire was self-administered by patients and returned by mail directly to the researchers \[[@B3], [@B5]--[@B7]\]. In our study, however, face-to-face interviews were performed by trained interviewers while patients were awaiting treatment. Since some patients felt uncomfortable about disclosing their use of CAM to their physicians, patients who completed a questionnaire survey right before (or after) seeing a doctor in the hospital might have a higher possibility of nondisclosure than those who completed it in their own homes. Consequently, our survey presumably underestimates the actual level of CAM use.

The limitations of the study are as follows. First, the current study is a cross-sectional one. Thus, there are difficulties in identifying any causal relationships between variables. Based solely on our results, it remains unclear whether the degree of patient satisfaction with conventional treatment was decreased because they used CAM or whether patients with a lower degree of satisfaction with conventional treatment tend to use CAM. Second, as mentioned earlier, we cannot completely rule out the possibility that our results might be an underestimate, although there were differences in the definition of CAM between this and the previous studies. This underestimate may affect the whole study. Continued research on the prevalence and predictors of CAM are needed in Korea. Despite these limitations, our results are of significance in that we extensively examined the status of CAM use and relevant factors in patients using a large sample size and various cancers in varying stages.

In conclusion, the use of CAM in patients with cancer can be interpreted as an attempt to explore all possible options, an expression of an active coping style, or an expression of unmet needs in the cancer care continuum. In any case, physicians should openly address the use of CAM and should identify whether there are other unmet supportive needs with their patients. Additionally, there should be sufficient communication between physicians and patients, which is essential for forming a trusting physician--patient relationship.
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###### 

Characteristics of cancer patients and complementary and alternative medicine use.

  Variables                                      Number of patients   Number of users   \%     *P* (*X* ^2^ test)
  ---------------------------------------------- -------------------- ----------------- ------ --------------------
  Total                                          2661                 678               25.5    
                                                                                               
  Age (year)                                                                                    
   18--39                                        185                  50                27.0    
   40--59                                        1171                 355               30.3    
   60--69                                        791                  176               22.3    
   70+                                           514                  97                18.9   \<0.001
  Gender                                                                                        
   Male                                          1412                 316               22.4    
   Female                                        1249                 362               29.0   \<0.001
  Education                                                                                     
   ≤Middle school                                1378                 295               21.4    
   High school                                   836                  249               29.8    
   ≥College                                      436                  130               29.8   \<0.001
  Marital status                                                                                
   Married                                       2212                 577               26.1    
   Not married (single, divorced, and widowed)   446                  100               22.4   0.105
  Monthly household income                                                                      
   \<1000 USD                                    803                  155               19.3    
   1000--3000 USD                                1138                 300               26.4    
   ≥3000 USD                                     705                  218               30.9   \<0.001
  National Health Insurance                                                                     
   National Health Insurance                     2297                 594               25.9    
   Medicaid/none/others                          364                  84                23.0   0.137
  Cancer type                                                                                   
   Stomach                                       464                  103               22.2    
   Lung                                          322                  77                23.9    
   Liver                                         254                  70                27.6    
   Colon/rectum                                  340                  64                18.8    
   Breast                                        379                  146               38.5    
   Cervix                                        113                  31                27.4    
   Others                                        789                  187               23.7   \<0.001
  Metastasis                                                                                    
   No                                            1901                 438               23.0    
   Yes                                           637                  202               31.7   \<0.001
  SEER stage                                                                                    
   In situ and local                             1038                 251               24.2    
   Regional                                      918                  235               25.6    
   Distant                                       468                  125               26.7    
   Unknown                                       237                  67                28.3   0.517
  Time since diagnosis                                                                          
   ≤12 months                                    985                  204               20.7    
   12--36 months                                 909                  234               25.7    
   36--60 months                                 385                  120               31.2    
   \>60 months                                   382                  120               31.4   \<0.001
  Trust in doctor                                                                               
   Very                                          2335                 575               24.6    
   Somewhat                                      292                  88                31.1    
   Not at all                                    34                   15                44.1   0.005
  Trust in hospital                                                                             
   Very                                          2125                 514               24.2    
   Somewhat                                      480                  141               29.4    
   Not at all                                    56                   23                41.1   0.002
  Satisfaction with medical service                                                             
   Very                                          1837                 439               23.9    
   Somewhat                                      673                  185               27.5    
   Not at all                                    151                  54                35.8   0.002
  EQ5D                                                                                          
   No problem                                    987                  223               22.6    
   One or more problem                           1674                 455               27.2   0.009

###### 

Predictors of complementary and alternative medicine use.

  Variables                            Univariate analysis   Multivariate analysis          
  ------------------------------------ --------------------- ----------------------- ------ ------------
  Basic model (*n* = 2515)                                                                   
   Age (year)                                                                                
    18--39                             1.00                  Reference               1.00   Reference
    40--59                             1.18                  0.83--1.66              1.36   0.93--1.99
    60--69                             0.77                  0.54--1.11              1.18   0.78--1.80
    70+                                0.63                  0.42--0.93              1.21   0.71--1.77
   Gender                                                                                    
    Male                               1.00                  Reference               1.00   Reference
    Female                             1.42                  1.19--1.69              1.17   0.93--1.48
   Education                                                                                 
    ≤Middle school                     1.00                  Reference               1.00   Reference
    High school                        1.56                  1.28--1.90              1.31   1.05--1.65
    ≥College                           1.56                  1.22--1.99              1.26   0.94--1.70
   Monthly household income                                                                  
    \<1000 USD                         1.00                  Reference               1.00   Reference
    1000--3000 USD                     1.50                  1.20--1.86              1.34   1.05--1.72
    ≥3000 USD                          1.87                  1.48--2.37              1.57   1.18--2.10
   Cancer type                                                                               
    Stomach                            1.00                  Reference               1.00   Reference
    Lung                               1.10                  0.79--1.54              1.20   0.84--1.72
    Liver                              1.33                  0.94--1.90              1.25   0.86--1.83
    Colon/rectum                       0.81                  0.57--1.15              0.77   0.53--1.11
    Breast                             2.20                  1.63--2.97              1.79   1.24--2.56
    Cervix                             1.33                  0.83--2.12              1.05   0.63--1.77
    Others                             1.09                  0.83--1.43              1.05   0.78--1.41
   Metastasis                                                                                
    No                                 1.00                  Reference               1.00   Reference
    Yes                                1.55                  1.27--1.89              1.55   1.26--1.91
   Time since diagnosis                                                                      
    ≤12 months                         1.00                  Reference               1.00   Reference
    12--36 months                      1.33                  1.07--1.64              1.32   1.05--1.65
    36--60 months                      1.73                  1.33--2.26              1.79   1.35--2.38
    \>60 months                        1.75                  1.35--2.29              1.76   1.33--2.34
                                                                                            
  Extended model\* 1 (*n* = 2515)                                                            
   Trust in doctor                                                                           
    Very                               1.00                  Reference               1.00   Reference
    Somewhat                           1.32                  1.01--1.73              1.26   0.94--1.67
    Not at all                         2.42                  1.22--4.79              2.38   1.13--5.00
  Extended model 2 (*n* = 2515)                                                              
   Trust in hospital                                                                         
    Very                               1.00                  Reference               1.00   Reference
    Somewhat                           1.30                  1.05--1.63              1.18   0.93--1.49
    Not at all                         2.19                  1.27--3.76              2.04   1.15--3.63
  Extended model 3 (*n* = 2515)                                                              
   Satisfaction with medical service                                                         
    Very                               1.00                  Reference               1.00   Reference
    Somewhat                           1.21                  1.99--1.78              1.14   0.92--1.41
    Not at all                         1.77                  1.25--2.52              1.61   1.11--2.34
  Extended model 4 (*n* = 2515)                                                              
   EQ5D                                                                                      
    No problems                        1.00                  Reference               1.00   Reference
    One or more problems               1.28                  1.06--1.54              1.23   1.01--1.50

\*Extended models are for individual current attitudes or status, controlling for the variables in the basic model.

###### 

Informational needs and complementary and alternative medicine use.

  Variables                                                                                                      Number of users/Number of patients   \%     Multivariate analysis\*   
  -------------------------------------------------------------------------------------------------------------- ------------------------------------ ------ ------------------------- ------------
  Needed information about the current status of my illness and its future course                                                                                                      
   No                                                                                                            143/751                              19.0   1.00                      Reference
   Yes                                                                                                           535/1910                             28.0   1.61                      1.29--2.02
  Needed information about tests and treatments                                                                                                                                        
   No                                                                                                            152/814                              18.7   1.00                      Reference
   Yes                                                                                                           526/1847                             28.5   1.68                      1.35--2.09
  Needed information about symptoms requiring a hospital visit                                                                                                                         
   No                                                                                                            187/897                              20.9   1.00                      Reference
   Yes                                                                                                           491/1764                             27.8   1.44                      1.17--1.78
  Needed an easy and accurate explanation of the benefits, side effects, and application of current medication                                                                         
   No                                                                                                            240/1103                             21.8   1.00                      Reference
   Yes                                                                                                           437/1556                             28.1   1.33                      1.10--1.62
  Needed information about what I could do at home for my health (e.g., exercise)                                                                                                      
   No                                                                                                            191/936                              20.4   1.00                      Reference
   Yes                                                                                                           487/1725                             28.2   1.49                      1.21--1.83
  Needed information about correct diet (foods to eat, foods to avoid)                                                                                                                 
   No                                                                                                            173/894                              19.4   1.00                      Reference
   Yes                                                                                                           504/1765                             28.6   1.63                      1.32--2.02
  Needed information about cancer-treating hospitals or clinics and physicians                                                                                                         
   No                                                                                                            243/1196                             20.3   1.00                      Reference
   Yes                                                                                                           435/1465                             29.7   1.51                      1.25--1.84
  Needed information about governmental financial support for medical expenses                                                                                                         
   No                                                                                                            137/708                              19.4   1.00                      Reference
   Yes                                                                                                           541/1951                             27.7   1.56                      1.25--1.96
  Needed information about hospice services                                                                                                                                            
   No                                                                                                            476/1925                             24.7   1.00                      Reference
   Yes                                                                                                           192/715                              26.9   1.04                      0.84--1.29

\*Multivariate analysis was performed on individual informational need, controlling for the variables in the basic model (gender, age, monthly income, cancer type, metastasis, and time since diagnosis).
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